Palasis Maria 4/A
4/A · Lyra Therapeutics, Inc. · Filed Jul 12, 2023
Insider Transaction Report
Form 4/AAmended
Palasis Maria
DirectorPresident & CEO
Transactions
- Award
Stock Option
2023-06-15+150,000→ 150,000 totalExercise: $2.99Exp: 2033-06-14→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following June 15, 2023.
- [F2]This Form 4 amendment is being filed to correct the expiration date of the stock option granted to the Reporting Person.